BR112016002979A8 - processo para a purificação de um composto de diaminofenotiazínio, processo para a purificação de azul de metileno e uso de um complexo de diaminofenotiazínio estabilizado protonado - Google Patents

processo para a purificação de um composto de diaminofenotiazínio, processo para a purificação de azul de metileno e uso de um complexo de diaminofenotiazínio estabilizado protonado Download PDF

Info

Publication number
BR112016002979A8
BR112016002979A8 BR112016002979A BR112016002979A BR112016002979A8 BR 112016002979 A8 BR112016002979 A8 BR 112016002979A8 BR 112016002979 A BR112016002979 A BR 112016002979A BR 112016002979 A BR112016002979 A BR 112016002979A BR 112016002979 A8 BR112016002979 A8 BR 112016002979A8
Authority
BR
Brazil
Prior art keywords
purification
diaminophenothiazine
complex
compound
protonated
Prior art date
Application number
BR112016002979A
Other languages
English (en)
Portuguese (pt)
Inventor
Eutick Malvin
Original Assignee
Eupharma Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2013903099A external-priority patent/AU2013903099A0/en
Application filed by Eupharma Pty Ltd filed Critical Eupharma Pty Ltd
Publication of BR112016002979A8 publication Critical patent/BR112016002979A8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18—[b, e]-condensed with two six-membered rings
    • C07D279/20—[b, e]-condensed with two six-membered rings with hydrogen atoms directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epidemiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Physics & Mathematics (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Preparation (AREA)
BR112016002979A 2013-08-15 2014-08-15 processo para a purificação de um composto de diaminofenotiazínio, processo para a purificação de azul de metileno e uso de um complexo de diaminofenotiazínio estabilizado protonado BR112016002979A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2013903099A AU2013903099A0 (en) 2013-08-15 Purification method and compounds
PCT/AU2014/000807 WO2015021500A1 (en) 2013-08-15 2014-08-15 Process for the purification of diaminophenothiazinium compounds

Publications (1)

Publication Number Publication Date
BR112016002979A8 true BR112016002979A8 (pt) 2020-02-04

Family

ID=52467850

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112016002979A BR112016002979A8 (pt) 2013-08-15 2014-08-15 processo para a purificação de um composto de diaminofenotiazínio, processo para a purificação de azul de metileno e uso de um complexo de diaminofenotiazínio estabilizado protonado

Country Status (14)

Country Link
US (1) US9701648B2 (cg-RX-API-DMAC7.html)
EP (1) EP3033331B1 (cg-RX-API-DMAC7.html)
JP (1) JP6111381B2 (cg-RX-API-DMAC7.html)
KR (1) KR101741235B1 (cg-RX-API-DMAC7.html)
CN (1) CN105612148B (cg-RX-API-DMAC7.html)
BR (1) BR112016002979A8 (cg-RX-API-DMAC7.html)
CA (1) CA2920505C (cg-RX-API-DMAC7.html)
DK (1) DK3033331T3 (cg-RX-API-DMAC7.html)
IL (1) IL243937A (cg-RX-API-DMAC7.html)
MX (1) MX354492B (cg-RX-API-DMAC7.html)
NZ (1) NZ630569A (cg-RX-API-DMAC7.html)
SG (1) SG11201601003PA (cg-RX-API-DMAC7.html)
TW (1) TWI629267B (cg-RX-API-DMAC7.html)
WO (1) WO2015021500A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3375777A1 (en) * 2017-03-15 2018-09-19 MIKROCHEM spol. s.r.o. Method for preparation of 3,7-bis-(dimethylamino)-phenothiazin-5-ium chloride or bromide
CN112358475B (zh) * 2020-11-30 2022-09-06 西北师范大学 一种苯并吡喃鎓-吩噻嗪衍生物及其制备方法和应用
CN116947783B (zh) * 2022-04-19 2026-04-17 英科隆生物技术(杭州)有限公司 一种电子媒介体的提纯方法
US20250270177A1 (en) * 2022-04-19 2025-08-28 Leadway (Hk) Limited Purification method for electron mediator

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909520A (en) 1959-10-20 Process for making acylated
DE1886C (de) 1877-12-15 1877-12-15 Basf Ag Verfahren zur darstellung blauer farbstoffe aus dimethylanilin und anderen tertiaeren aromatischen monaminen
GB1293757A (en) 1968-10-22 1972-10-25 Paines & Byrne Ltd A nerve stain composition
GB0327672D0 (en) * 2003-11-28 2003-12-31 Photopharmica Ltd Developments in biologically active methylene blue derivatives (phenothiazines)
BRPI0416928A (pt) * 2003-11-28 2007-01-16 Photopharmica Ltd desenvolvimento de derivados biologicamente ativos de azul de metileno
JP5186212B2 (ja) * 2004-09-23 2013-04-17 ウィスタ ラボラトリーズ リミテッド メチルチオニニウム塩化物(mtc)などのジアミノフェノチアジニウム化合物を化学合成および精製する方法
WO2006032879A2 (en) 2004-09-23 2006-03-30 Wista Laboratories Ltd. Methods of chemical synthesis and purification of diaminophenothiazinium compounds including methylthioninium chloride (mtc)
MY162313A (en) * 2006-07-11 2017-05-31 Wista Lab Ltd Methods of synthesis and/or purification of diaminophenothiazinium compounds
FR2903696B1 (fr) 2006-07-12 2011-02-11 Provence Technologies Procede de purification de composes diaminophenothiazium
KR101888713B1 (ko) * 2011-02-11 2018-08-14 위스타 레보레이토리스 리미티드 페노티아진 디아미늄 염 및 이의 용도

Also Published As

Publication number Publication date
WO2015021500A1 (en) 2015-02-19
SG11201601003PA (en) 2016-03-30
TWI629267B (zh) 2018-07-11
EP3033331A4 (en) 2017-01-18
KR101741235B1 (ko) 2017-05-29
CA2920505C (en) 2018-04-03
DK3033331T3 (da) 2018-04-30
CA2920505A1 (en) 2015-02-19
IL243937A0 (en) 2016-04-21
EP3033331A1 (en) 2016-06-22
EP3033331B1 (en) 2018-02-21
IL243937A (en) 2017-01-31
CN105612148A (zh) 2016-05-25
US20160200696A1 (en) 2016-07-14
MX2016002085A (es) 2016-06-23
MX354492B (es) 2018-03-07
JP2016528237A (ja) 2016-09-15
AU2014306354A1 (en) 2016-02-18
US9701648B2 (en) 2017-07-11
KR20160042929A (ko) 2016-04-20
TW201527287A (zh) 2015-07-16
CN105612148B (zh) 2018-09-14
JP6111381B2 (ja) 2017-04-05
NZ630569A (en) 2017-06-30

Similar Documents

Publication Publication Date Title
BR112015022795A2 (pt) processo de conversão de hmf em fdca
BR112015023513A2 (pt) métodos de purificação de rna
CL2018000070A1 (es) Modulares de diaciglicerol aciltransderasa 2 (dgta2)
CR20130620A (es) 4-aril-n-fenil-1,3,5-triazin-2-aminas que contienen un grupo sulfoximina
BR112015005369A2 (pt) inibidores de usp30 e métodos para sua utilização
CR20150629A (es) Compuestos químicos
MX389510B (es) Composiciones y métodos para el uso de ésteres de forbol para el tratamiento de accidentes cerebrovasculares.
EA201791850A1 (ru) Борсодержащие малые молекулы
BR112018011567A2 (pt) método de purificação de uma proteína de interesse, e, uso de um método.
BR112013020513A2 (pt) adoçante stevia altamente solúvel
BR112017004524A2 (pt) pirrolopirimidinas para uso na infecção pelo vírus da gripe
MX2015008241A (es) Metodos para el tratamiento de espasmos gastrointestinales.
BR112015020795A2 (pt) derivados de pirazol novos
BR112015012808A2 (pt) composição de cuidado oral
BR112015009600A2 (pt) piridina-2-amidas úteis como agonistas cb2
BR102015012091A8 (pt) método para a preparação de uma solução de albumina humana, e, composição
MX2017003205A (es) Composiciones antimicrobianas y sus metodos de uso.
CL2010000918A1 (es) Compuestos derivados de hidroxibencilo; uso de dichos compuestos para formar complejo con un cation; metodo para extraer un metal con dicho compuesto; el complejo en si; uso de dicho complejo como purificador de aire y como catalizador; y kit para descontaminar un liquido contaminado con un metal.
BR112015030088A2 (pt) aprimoramentos em ou referentes a compostos orgânicos
EA201990163A1 (ru) Консервация микроорганизмов
MX2015016665A (es) Composicion dispersante liquida para yeso.
BR112018007719A2 (pt) método de preparação para substância p-fenilenodiamina substituída por aril
MX2016003337A (es) Tratamiento de oxidos de nitrogeno en corrientes de gas de humero.
CL2018001407A1 (es) Compuestos de 1,3,4-tiadiazol y su uso en el tratamiento del cáncer
BR112015020783A2 (pt) célula de eletrodo microlamelar e seu uso

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.